Detalhe da pesquisa
1.
A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion-positive non-small cell lung cancer.
Cancer
; 130(5): 683-691, 2024 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37905752
2.
Estimation and expected sample size in Simon's two-stage designs that stop as early as possible.
Pharm Stat
; 21(5): 879-894, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35191174
3.
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.
Nat Med
; 29(3): 588-592, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36732628
4.
Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy.
Eur J Cancer
; 127: 240-250, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31956037
5.
Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.
Nat Med
; 30(1): 304, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37460757